時間 | 主題 | |||
---|---|---|---|---|
12:50 ~ 13:00 |
opening
講者:
黃昭淵
|
黃昭淵 |
||
Post-EAU 2025: Female Urology/ pediatric (On-line)
講者:
黃欣媚
座長:
林子平, 何承勳 |
黃欣媚 |
林子平, 何承勳 |
||
Post-EAU 2025: BPH/ Andrology (On-line)
講者:
詹鎮豪
座長:
林子平, 何承勳 |
詹鎮豪 |
林子平, 何承勳 |
||
Post-EAU 2025: Urolithiasis/ transplantation
講者:
陳浩瑋
座長:
林子平, 何承勳 |
陳浩瑋 |
林子平, 何承勳 |
||
13:45 ~ 14:00 |
Break
講者:
All
|
All |
||
The Best of EAU25 in Urothelial Cancer (On-line)
講者:
J.Boormans, Rotterdam (NL)
座長:
闕士傑, 廖俊厚 |
J.Boormans, Rotterdam (NL) |
闕士傑, 廖俊厚 |
||
The Best of EAU25 in Functional Urology (On-line)
講者:
Peyronnet, Rennes (FR)
座長:
闕士傑, 廖俊厚 |
Peyronnet, Rennes (FR) |
闕士傑, 廖俊厚 |
||
The Best of EAU25 in Imaging (On-line)
講者:
J.Walz, Marseille (FR)
座長:
闕士傑, 廖俊厚 |
J.Walz, Marseille (FR) |
闕士傑, 廖俊厚 |
||
15:30 ~ 15:50 |
Panel Discussion: Bridging European and Taiwanese Insights in Urology
講者:
All
|
All |
||
Re-thinking the First Step in mRCC: Bringing Evidence-Based Choices intoTaiwan’s NHI and Self-Pay Practice
講者:
蔡昇翰
座長:
林文榮
|
蔡昇翰 |
林文榮 |
||
Navigating and Tailoring First-Line Therapy in metastatic/ advanced Renal Cell Carcinoma: Efficacy, and Side Effect Considerations
講者:
王紹全
座長:
許兆畬
|
王紹全 |
許兆畬 |
||
Clinical outcomes ineligible patients for adjuvant therapy after nephrectomy based on the KEYNOTE-564 study criteria
講者:
郭威廷
座長:
虞凱傑
|
郭威廷 |
虞凱傑 |
||
17:00 ~ 17:10 |
Break
講者:
All
|
All |
||
Beyond BRCA: examining the evidence for novel PARPi combinations in mCRPC
講者:
李香瑩
座長:
陳冠州
|
李香瑩 |
陳冠州 |
||
Breakthrough treatment for all comers: defeating prostate cancer together
講者:
廖丞晞
座長:
鍾旭東
|
廖丞晞 |
鍾旭東 |
||
New Horizons:Treatment Intensification in CSPC
講者:
陳毓騏
座長:
蔡育賢
|
陳毓騏 |
蔡育賢 |
||
18:10 ~ 18:20 |
Discussion
講者:
All
座長:
陳冠州
|
All |
陳冠州 |
|
18:20 ~ 18:30 |
Closing
講者:
查岱龍
|
查岱龍 |
時間 | 主題 | |||
---|---|---|---|---|
09:00 ~ 09:10 |
opening
講者:
余家政
|
余家政 |
||
09:10 ~ 09:40 |
Transforming Perioperative Therapy : Challenges and Opportunities in Future MIBC Treatments
講者:
高建璋
座長:
闕士傑
|
高建璋 |
闕士傑 |
|
09:40 ~ 10:10 |
The Role of IO Therapy in the Adjuvant Setting for Muscle-Invasive Bladder Cancer (MIBC)
講者:
陳鴻毅
座長:
李經家
|
陳鴻毅 |
李經家 |
|
10:10 ~ 10:40 |
LA/mUC Treatment Evolution: Insights from Congress and Real-World Application of ADC+IO
講者:
吳書丞
座長:
王賢祥
|
吳書丞 |
王賢祥 |
|
10:40 ~ 11:10 |
Advances and update of mUC upfront therapy in 2025
講者:
楊晨洸
座長:
張延驊
|
楊晨洸 |
張延驊 |
|
11:10 ~ 11:20 |
Discussion
講者:
All
座長:
張延驊
|
All |
張延驊 |
|
11:20 ~ 11:30 |
Closing
講者:
李經家
|
李經家 |